Revelation Biosciences Ownership 2024 | Who Owns Revelation Biosciences Now?
Institutional Ownership
101.40%
Insider Ownership
0.32%
Retail Ownership
-1.72%
Institutional Holders
10.00
Revelation Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALTIUM CAPITAL MANAGEMENT LP | 100.00% | 0.03% | 37,198 | 37,198 | 100.00% | 48,357,000 | Mar 31, 2023 |
WALLEYE CAPITAL LLC | 100.00% | 0.00% | 174,685 | 174,685 | 100.00% | 227,091,000 | Mar 31, 2023 |
CVI HOLDINGS, LLC | 100.00% | 0.02% | 33,204 | 33,204 | 100.00% | 43,165,000 | Mar 31, 2023 |
AXA S.A. | 100.00% | 0.00% | 55,971 | 55,971 | 100.00% | 72,762,000 | Mar 31, 2023 |
HUDSON BAY CAPITAL MANAGEMENT LP | 100.00% | 0.00% | 109,520 | 109,520 | 100.00% | 142,376,000,000 | Mar 31, 2023 |
ANSON FUNDS MANAGEMENT LP | 100.00% | 0.05% | 213,509 | 213,509 | 100.00% | 277,562,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 100.00% | 0.20% | 180,431 | 180,431 | 100.00% | 234,560,000 | Mar 31, 2023 |
UBS GROUP AG | 8.84% | - | 1,362 | 1,362 | 100.00% | 1,771,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.80% | - | 123 | 123 | 100.00% | 160,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.02% | - | 3 | 3 | 100.00% | 4,000 | Mar 31, 2023 |
MAYFLOWER FINANCIAL ADVISORS, LLC | - | - | - | -613 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -123 | -100.00% | - | Mar 31, 2023 |
AXA S.A. | - | - | - | -55,971 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -125 | -100.00% | - | Mar 31, 2023 |
VALEO FINANCIAL ADVISORS, LLC | - | - | - | -286 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -1,126 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -3,110 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -243 | -100.00% | - | Mar 31, 2023 |
REBALANCE, LLC | - | - | - | -2,453 | -100.00% | - | Mar 31, 2023 |
Revelation Biosciences's largest institutional shareholder is ALTIUM CAPITAL MANAGEMENT LP, holding 100.00% of the company's total share outstanding, currently valued at $48.36M. The top 10 institutional shareholders own together 709.66% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | 100.00% | 0.20% | 180,431 | 180,431 | 100.00% | 234,560,000 | Mar 31, 2023 |
ANSON FUNDS MANAGEMENT LP | 100.00% | 0.05% | 213,509 | 213,509 | 100.00% | 277,562,000 | Mar 31, 2023 |
ALTIUM CAPITAL MANAGEMENT LP | 100.00% | 0.03% | 37,198 | 37,198 | 100.00% | 48,357,000 | Mar 31, 2023 |
CVI HOLDINGS, LLC | 100.00% | 0.02% | 33,204 | 33,204 | 100.00% | 43,165,000 | Mar 31, 2023 |
WALLEYE CAPITAL LLC | 100.00% | 0.00% | 174,685 | 174,685 | 100.00% | 227,091,000 | Mar 31, 2023 |
HUDSON BAY CAPITAL MANAGEMENT LP | 100.00% | 0.00% | 109,520 | 109,520 | 100.00% | 142,376,000,000 | Mar 31, 2023 |
AXA S.A. | 100.00% | 0.00% | 55,971 | 55,971 | 100.00% | 72,762,000 | Mar 31, 2023 |
UBS GROUP AG | 8.84% | - | 1,362 | 1,362 | 100.00% | 1,771,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.80% | - | 123 | 123 | 100.00% | 160,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.02% | - | 3 | 3 | 100.00% | 4,000 | Mar 31, 2023 |
MAYFLOWER FINANCIAL ADVISORS, LLC | - | - | - | -613 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -123 | -100.00% | - | Mar 31, 2023 |
AXA S.A. | - | - | - | -55,971 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -125 | -100.00% | - | Mar 31, 2023 |
VALEO FINANCIAL ADVISORS, LLC | - | - | - | -286 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -1,126 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -3,110 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -243 | -100.00% | - | Mar 31, 2023 |
REBALANCE, LLC | - | - | - | -2,453 | -100.00% | - | Mar 31, 2023 |
The largest Revelation Biosciences shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 180.43K shares of Revelation Biosciences (REVB), representing 0.20% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ANSON FUNDS MANAGEMENT LP | 100.00% | 0.05% | 213,509 | 213,509 | 100.00% | 277,562,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 100.00% | 0.20% | 180,431 | 180,431 | 100.00% | 234,560,000 | Mar 31, 2023 |
WALLEYE CAPITAL LLC | 100.00% | 0.00% | 174,685 | 174,685 | 100.00% | 227,091,000 | Mar 31, 2023 |
HUDSON BAY CAPITAL MANAGEMENT LP | 100.00% | 0.00% | 109,520 | 109,520 | 100.00% | 142,376,000,000 | Mar 31, 2023 |
AXA S.A. | 100.00% | 0.00% | 55,971 | 55,971 | 100.00% | 72,762,000 | Mar 31, 2023 |
ALTIUM CAPITAL MANAGEMENT LP | 100.00% | 0.03% | 37,198 | 37,198 | 100.00% | 48,357,000 | Mar 31, 2023 |
CVI HOLDINGS, LLC | 100.00% | 0.02% | 33,204 | 33,204 | 100.00% | 43,165,000 | Mar 31, 2023 |
UBS GROUP AG | 8.84% | - | 1,362 | 1,362 | 100.00% | 1,771,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.80% | - | 123 | 123 | 100.00% | 160,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.02% | - | 3 | 3 | 100.00% | 4,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -123 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -125 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -243 | -100.00% | - | Mar 31, 2023 |
VALEO FINANCIAL ADVISORS, LLC | - | - | - | -286 | -100.00% | - | Mar 31, 2023 |
MAYFLOWER FINANCIAL ADVISORS, LLC | - | - | - | -613 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -1,126 | -100.00% | - | Mar 31, 2023 |
REBALANCE, LLC | - | - | - | -2,453 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -3,110 | -100.00% | - | Mar 31, 2023 |
AXA S.A. | - | - | - | -55,971 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Revelation Biosciences's largest institutional buyer is ANSON FUNDS MANAGEMENT LP. The company purchased 213.51K stocks of REVB, valued at $277.56M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AXA S.A. | - | - | - | -55,971 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -3,110 | -100.00% | - | Mar 31, 2023 |
REBALANCE, LLC | - | - | - | -2,453 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -1,126 | -100.00% | - | Mar 31, 2023 |
MAYFLOWER FINANCIAL ADVISORS, LLC | - | - | - | -613 | -100.00% | - | Mar 31, 2023 |
VALEO FINANCIAL ADVISORS, LLC | - | - | - | -286 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -243 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -125 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -123 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.02% | - | 3 | 3 | 100.00% | 4,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.80% | - | 123 | 123 | 100.00% | 160,000 | Mar 31, 2023 |
UBS GROUP AG | 8.84% | - | 1,362 | 1,362 | 100.00% | 1,771,000 | Mar 31, 2023 |
CVI HOLDINGS, LLC | 100.00% | 0.02% | 33,204 | 33,204 | 100.00% | 43,165,000 | Mar 31, 2023 |
ALTIUM CAPITAL MANAGEMENT LP | 100.00% | 0.03% | 37,198 | 37,198 | 100.00% | 48,357,000 | Mar 31, 2023 |
AXA S.A. | 100.00% | 0.00% | 55,971 | 55,971 | 100.00% | 72,762,000 | Mar 31, 2023 |
HUDSON BAY CAPITAL MANAGEMENT LP | 100.00% | 0.00% | 109,520 | 109,520 | 100.00% | 142,376,000,000 | Mar 31, 2023 |
WALLEYE CAPITAL LLC | 100.00% | 0.00% | 174,685 | 174,685 | 100.00% | 227,091,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 100.00% | 0.20% | 180,431 | 180,431 | 100.00% | 234,560,000 | Mar 31, 2023 |
ANSON FUNDS MANAGEMENT LP | 100.00% | 0.05% | 213,509 | 213,509 | 100.00% | 277,562,000 | Mar 31, 2023 |
As of Mar 31 2023, Revelation Biosciences's biggest institutional seller is AXA S.A.. The company sold -55.97K shares of REVB, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ANSON FUNDS MANAGEMENT LP | 100.00% | 0.05% | 213,509 | 213,509 | 100.00% | 277,562,000 | Mar 31, 2023 |
SABBY MANAGEMENT, LLC | 100.00% | 0.20% | 180,431 | 180,431 | 100.00% | 234,560,000 | Mar 31, 2023 |
WALLEYE CAPITAL LLC | 100.00% | 0.00% | 174,685 | 174,685 | 100.00% | 227,091,000 | Mar 31, 2023 |
HUDSON BAY CAPITAL MANAGEMENT LP | 100.00% | 0.00% | 109,520 | 109,520 | 100.00% | 142,376,000,000 | Mar 31, 2023 |
AXA S.A. | 100.00% | 0.00% | 55,971 | 55,971 | 100.00% | 72,762,000 | Mar 31, 2023 |
ALTIUM CAPITAL MANAGEMENT LP | 100.00% | 0.03% | 37,198 | 37,198 | 100.00% | 48,357,000 | Mar 31, 2023 |
CVI HOLDINGS, LLC | 100.00% | 0.02% | 33,204 | 33,204 | 100.00% | 43,165,000 | Mar 31, 2023 |
UBS GROUP AG | 8.84% | - | 1,362 | 1,362 | 100.00% | 1,771,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.80% | - | 123 | 123 | 100.00% | 160,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.02% | - | 3 | 3 | 100.00% | 4,000 | Mar 31, 2023 |
Revelation Biosciences's largest new institutional shareholder by number of shares is ANSON FUNDS MANAGEMENT LP, purchased 213.51K shares, valued at $277.56M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AXA S.A. | - | - | - | -55,971 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | - | - | - | -3,110 | -100.00% | - | Mar 31, 2023 |
REBALANCE, LLC | - | - | - | -2,453 | -100.00% | - | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -1,126 | -100.00% | - | Mar 31, 2023 |
MAYFLOWER FINANCIAL ADVISORS, LLC | - | - | - | -613 | -100.00% | - | Mar 31, 2023 |
VALEO FINANCIAL ADVISORS, LLC | - | - | - | -286 | -100.00% | - | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -243 | -100.00% | - | Mar 31, 2023 |
CWM, LLC | - | - | - | -125 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | - | - | - | -123 | -100.00% | - | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -4 | -100.00% | - | Mar 31, 2023 |
Revelation Biosciences's largest sold out institutional shareholder by shares sold is AXA S.A., sold -55.97K shares, valued at -, as of undefined.
Revelation Biosciences Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
T. Rowe Price Small-Cap Value Fund, Inc. | 0.06% | 467,934 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.05% | 121,263 | - | - | Mar 28, 2024 |
NEXPOINT FUNDS I | 0.00% | 16,989 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 35,709 | - | - | Feb 29, 2024 |
NEUBERGER BERMAN ALTERNATIVE FUNDS | 0.00% | 900 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 12,000 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 5,940 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 1,542 | - | - | Feb 29, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 5,395 | - | - | Dec 31, 2023 |
Revelation Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price Small-Cap Value Fund, Inc.", owning 467.93K shares, compromising 0.06% of its total assets.
Revelation Biosciences Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 22 | 10 | -23.08% |
30 Sep, 22 | 13 | 18.18% |
30 Jun, 22 | 11 | -26.67% |
31 Mar, 22 | 15 | 650.00% |
31 Dec, 21 | 2 | - |
As of 31 Dec 22, 10 institutions are holding Revelation Biosciences's shares, representing a decrease of -23.08% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 22 | 2,241,719 | -0.35% |
30 Sep, 22 | 2,249,678 | -30.10% |
30 Jun, 22 | 3,218,346 | 6.68% |
31 Mar, 22 | 3,016,821 | 4593.40% |
31 Dec, 21 | 64,278 | - |
Revelation Biosciences (REVB) has 2.24M shares outstanding as of 31 Dec 22, down -0.35% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 22 | 101.40% | 0.98% |
30 Sep, 22 | 101.76% | 0.48% |
30 Jun, 22 | 145.58% | 0.78% |
31 Mar, 22 | 136.46% | 1614.18% |
31 Dec, 21 | 2.91% | - |
As of 31 Dec 22, Revelation Biosciences is held by 101.40% institutional shareholders, representing a 0.98% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 22 | 3 | -62.50% |
30 Sep, 22 | 8 | 60.00% |
30 Jun, 22 | 5 | -66.67% |
31 Mar, 22 | 15 | 650.00% |
31 Dec, 21 | 2 | - |
3 institutional shareholders have increased their position in REVB stock as of 31 Dec 22 compared to 8 in the previous quarter (a -62.50% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 22 | 1 | - |
30 Sep, 22 | - | -100.00% |
30 Jun, 22 | 1 | - |
31 Mar, 22 | - | - |
31 Dec, 21 | - | - |
1 institutional shareholders have reduced their position in REVB stock as of 31 Dec 22 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 22 | 10 | -23.08% | 2,241,719 | -0.35% | 101.40% | 0.98% | 3 | -62.50% | 1 | - |
30 Sep, 22 | 13 | 18.18% | 2,249,678 | -30.10% | 101.76% | 0.48% | 8 | 60.00% | - | -100.00% |
30 Jun, 22 | 11 | -26.67% | 3,218,346 | 6.68% | 145.58% | 0.78% | 5 | -66.67% | 1 | - |
31 Mar, 22 | 15 | 650.00% | 3,016,821 | 4593.40% | 136.46% | 1614.18% | 15 | 650.00% | - | - |
31 Dec, 21 | 2 | - | 64,278 | - | 2.91% | - | 2 | - | - | - |
Revelation Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Revelation Biosciences's stock was made by TIDMARSH GEORGE F on Dec 12 2023, selling 27,771 shares at $0.52 per share (valued at $14.44K). The last insider buy of REVB was made by TIDMARSH GEORGE F on Apr 19 2023, buying 25,000 shares at $1.16 per share (worth $29.00K).
Revelation Biosciences Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | 2 | - |
Q3 2023 | - | 4 | - |
Q2 2023 | 6 | - | - |
Q1 2023 | 2 | - | - |
Q4 2022 | - | - | - |
Q1 2022 | - | 1 | - |
Q4 2021 | - | - | - |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Revelation Biosciences's insiders, as of Q4 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | 2 | - |
Q3 2023 | - | 4 | - |
Q2 2023 | 2 | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Revelation Biosciences's stocks.
Revelation Biosciences Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
BWV | Onconetix, Inc. |
KPRX | Kiora Pharmaceuticals, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
PHIO | Phio Pharmaceuticals Corp. |
QNRX | Quoin Pharmaceuticals, Ltd. |
RNAZ | TransCode Therapeutics, Inc. |
HILS | Tharimmune, Inc. |
VRAX | Virax Biolabs Group Limited |
CYTO | Altamira Therapeutics Ltd. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
ZURA | Zura Bio Limited |
REVB Ownership FAQ
Who Owns Revelation Biosciences?
Revelation Biosciences is owned by institutional shareholders (101.40%), insiders (0.32%), and public (-1.72%). The largest institutional shareholder of Revelation Biosciences is ALTIUM CAPITAL MANAGEMENT LP (100.00% of total shares) and the top mutual fund owner is T. Rowe Price Small-Cap Value Fund, Inc. (0.06% of total shares).
Who are the major institutional shareholders of Revelation Biosciences?
Revelation Biosciences's major institutional shareholders are ALTIUM CAPITAL MANAGEMENT LP, WALLEYE CAPITAL LLC, CVI HOLDINGS, LLC, AXA S.A., and HUDSON BAY CAPITAL MANAGEMENT LP. The top five shareholders own together 500.00% of the company's share outstanding.
How many Revelation Biosciences shareholders are there?
As of Dec 2022, there are 10 institutional shareholders of Revelation Biosciences.
What percentage of Revelation Biosciences is owned by ALTIUM CAPITAL MANAGEMENT LP?
ALTIUM CAPITAL MANAGEMENT LP owns 37.2K shares of Revelation Biosciences, representing 100.00% of the company's total shares outstanding, valued at $48.36M (as of Mar 2023).
What percentage of Revelation Biosciences is owned by WALLEYE CAPITAL LLC?
As of Mar 2023, WALLEYE CAPITAL LLC holds 174.68K shares of Revelation Biosciences (REVB), compromising 100.00% of the company, valued at $227.09M.
What percentage of Revelation Biosciences is owned by CVI HOLDINGS, LLC?
CVI HOLDINGS, LLC is the third largest holder of Revelation Biosciences. The company owns 33.2K of the company's shares outstanding (worth $43.16M).